BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 31821331)

  • 1. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
    von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
    Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.
    Halder R; Seth T; Chaturvedi PK; Mishra P; Mahapatra M; Pati HP; Tyagi S; Saxena R
    Blood Cells Mol Dis; 2020 Sep; 84():102445. PubMed ID: 32480243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
    Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
    Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
    Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
    J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients.
    Cabanillas Stanchi KM; Queudeville M; Malaval C; Feucht J; Schlegel P; Dobratz M; Seitz C; Müller I; Lang P; Handgretinger R; Döring M
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2779-2791. PubMed ID: 31446489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
    Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
    Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
    Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum biomarkers to differentiate Gram-negative, Gram-positive and fungal infection in febrile patients.
    Niu D; Huang Q; Yang F; Tian W; Li C; Ding L; Fang HC; Zhao Y
    J Med Microbiol; 2021 Jul; 70(7):. PubMed ID: 34259621
    [No Abstract]   [Full Text] [Related]  

  • 10. Procalcitonin and C-reactive protein predict infection in hematopoietic stem cell transplantation patients.
    Li S; Gu J; Nan W; Zhang N; Qin L; Su M; Jia M
    Leuk Res; 2021 Jun; 105():106574. PubMed ID: 33836480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of interleukin-6, interleukin-10, procalcitonin and C-reactive protein in identifying high-risk febrile illness in pediatric cancer patients: A prospective observational study.
    Xu XJ; Luo ZB; Xia T; Song H; Yang SL; Xu WQ; Ni YR; Ning Zhao ; Tang YM
    Cytokine; 2019 Apr; 116():1-6. PubMed ID: 30684912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
    Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia].
    Fu Y; Jiang H; Li LX; Chen J; Zhang JL; Wang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1296-300. PubMed ID: 24156453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study.
    Işlak Mutcalı S; Saltoğlu N; Balkan İİ; Özaras R; Yemişen M; Tabak F; Mert A; Öztürk R; Öngören Ş; Başlar Z; Aydın Y; Ferhanoğlu B; Soysal T
    Turk J Haematol; 2016 Dec; 33(4):304-310. PubMed ID: 26377840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin as a marker of Gram-negative bloodstream infections in hematological patients with febrile neutropenia.
    Luo X; Chen S; Zhang J; Ren J; Chen M; Lin K; Zhu H; Zheng R; Zheng Z; Chen Z; Hu J; Yang T
    Leuk Lymphoma; 2019 Oct; 60(10):2441-2448. PubMed ID: 30806111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
    Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V
    Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia.
    Giamarellos-Bourboulis EJ; Grecka P; Poulakou G; Anargyrou K; Katsilambros N; Giamarellou H
    Clin Infect Dis; 2001 Jun; 32(12):1718-25. PubMed ID: 11360214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients.
    Marková M; Brodská H; Malíčková K; Válková V; Cetkovský P; Kolář M; Haluzík M
    Support Care Cancer; 2013 Oct; 21(10):2733-42. PubMed ID: 23712521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants.
    Milcent K; Faesch S; Gras-Le Guen C; Dubos F; Poulalhon C; Badier I; Marc E; Laguille C; de Pontual L; Mosca A; Nissack G; Biscardi S; Le Hors H; Louillet F; Dumitrescu AM; Babe P; Vauloup-Fellous C; Bouyer J; Gajdos V
    JAMA Pediatr; 2016 Jan; 170(1):62-9. PubMed ID: 26595253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance enhancement of procalcitonin by high-sensitivity C-reactive protein at the optimal cutoff in predicting bacteremia in emergency department adult patients.
    Kok VC; Lin CT; Yeh CB; Yang CC; Horng JT
    Scand J Clin Lab Invest; 2019; 79(1-2):25-31. PubMed ID: 30628465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.